Mr Colin Law > Fangda Partners > Hong Kong, Hong Kong > Lawyer Profile

The team at Fangda Partners is known for its deep PRC law expertise, and handles a variety of mandates for clients in the TMT, logistics, healthcare, and education sectors. Known for handling both public and private M&A, the group represents numerous targets and financial investors. Colin Law leads the team with his broad experience in advising bulge bracket investment banks on public takeovers and privatizations. Raymond Chan contributes his knowledge of venture capital and cross-border M&A issues, while Xiaotong Jia primarily focuses on private equity and investment matters, regularly representing consortiums and funds.

Colin Law leads the team at Fangda Partners, which is known for handling a broad range of transactions with elements of China law. The practice regularly assists financial and strategic investors across a variety of sectors, including education, energy, and chemical. Law represents a number of bulge bracket investment banks on takeovers and privatisation matters, particularly in relation to the biotech and healthcare sectors.

A range of Chinese and multinational corporates rely on Fangda Partners‘ Hong Kong team for the breadth of its transactional and dispute resolution capabilities. Corporate and capital market deals are at the core of the firm’s transactional offering, with the team guiding clients through the intricacies of cross-border debt mandates, private equity deals, panda bond transactions, high-value M&A work, and energy projects for both private and public entities. Another significant aspect of the practice is dispute resolution, where the team has recently been active in representing clients in the pharmaceutical, manufacturing, and electronics sectors, often before the Court of Appeal. Taking the lead in numerous of these listings and global matters is Colin Law, a dual-qualified partner in the UK and Hong Kong. Law’s expertise extends to the biotech sector, and he is frequently involved in a substantial volume of public M&A and take-private matters. Christine Chen offers ‘solid advice on standard transactions as well as ad hoc complex questions’ related to all aspects of debt capital markets transactions, in addition to excelling in various financial regulatory matters and US securities law-related mandates. In the energy infrastructure sphere, Michael Tam‘s leadership stands out. Tam’s role as head, combined with his presence in Hong Kong and Shenzhen, well-positions him to effectively handle development and project financing mandates. Tam is supported by Joe Biqing Zhou , who has recently played a key role in landmark Hong Kong and Chinese infrastructure projects. Fangda’s litigation arm is guided by founding partner Peter Yuen, whose expertise extends seamlessly to handling conventional corporate and shareholder disputes. Yuen’s capabilities also encompass international arbitration proceedings, especially those entwined with Chinese complexities. Olga Boltenko brings specialist strength in the area of investment protection and related arbitrations, and has acted as legal counsel in investor-state disputes under the auspices of the Permanent Court of Arbitration.

Fangda Partners is particularly effective at advising PRC issuers across a range of core ECM work, as well as in the context of public M&A. In this context, the firm is able to draw from a strong grounding in regulatory issues ensuring that complex transactional work is effectively handled, and also that listed clients are able to receive ongoing compliance work on an ad-hoc basis. Team head Colin Law is the driving force behind the firm’s IPO practice and is particularly adept at handling listings within the biotech space.